Oral eplerenone for the management of chronic central serous chorioretinopathy

AIM: To examine eplerenone (Inspra, Pfizer), a mineralocorticoid receptor antagonist, as a treatment option for chronic central serous chorioretinopathy (CSCR). METHODS: A retrospective consecutive case series was conducted for patients receiving oral eplerenone for chronic CSCR. At baseline and eac...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Int J Ophthalmol
Huvudupphovsmän: Singh, Rishi P, Sears, Jonathan E, Bedi, Rumneek, Schachat, Andrew P, Ehlers, Justis P, Kaiser, Peter K
Materialtyp: Artigo
Språk:Inglês
Publicerad: International Journal of Ophthalmology Press 2015
Ämnen:
Clinical Research
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC4413566/
https://ncbi.nlm.nih.gov/pubmed/25938046
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3980/j.issn.2222-3959.2015.02.17
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk